OVIT (OncoVista Innovative Therapies) 3-Year ROIIC % : 0.00% (As of Dec. 2014)

View and export this data going back to 2005. Start your Free Trial

What is OncoVista Innovative Therapies 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. OncoVista Innovative Therapies's 3-Year ROIIC % for the quarter that ended in Dec. 2014 was 0.00%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for OncoVista Innovative Therapies's 3-Year ROIIC % or its related term are showing as below:

OVIT's 3-Year ROIIC % is not ranked ^*
in the Biotechnology industry.
Industry Median: -13.73
* Ranked among companies with meaningful 3-Year ROIIC % only.

OncoVista Innovative Therapies 3-Year ROIIC % Historical Data

The historical data trend for OncoVista Innovative Therapies's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoVista Innovative Therapies 3-Year ROIIC % Chart

OncoVista Innovative Therapies Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

3-Year ROIIC %

Get a 7-Day Free Trial

OncoVista Innovative Therapies Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
3-Year ROIIC %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of OncoVista Innovative Therapies's 3-Year ROIIC %

For the Biotechnology subindustry, OncoVista Innovative Therapies's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoVista Innovative Therapies's 3-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoVista Innovative Therapies's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where OncoVista Innovative Therapies's 3-Year ROIIC % falls into.

OncoVista Innovative Therapies 3-Year ROIIC % Calculation

OncoVista Innovative Therapies's 3-Year ROIIC % for the quarter that ended in Dec. 2014 is calculated as:

3-Year ROIIC %	=	3-Year Incremental Net Operating Profit After Taxes (NOPAT)^**	/	3-Year Incremental Invested Capital^**
	=	( -2.546 (Dec. 2014) - -2.201 (Dec. 2011) )	/	( 1.616 (Dec. 2014) - 0.774 (Dec. 2011) )
	=	-0.345	/	0.842
	=	-40.97%^***

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

OncoVista Innovative Therapies (OTCPK:OVIT) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.

OncoVista Innovative Therapies 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of OncoVista Innovative Therapies's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoVista Innovative Therapies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoVista Innovative Therapies Inc (OTCPK:OVIT) » Definitions » 3-Year ROIIC %

Comparable Companies

Traded in Other Exchanges

N/A

Address

14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245

Website

http://www.oncovista.com

OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.

Executives

Alexander Ruckdaeschel	director	123 EAST 83RD STREET, APT 3-B, NEW YORK NY 10028
Paul A Mieyal	director	C/O WEXFORD CAPITAL LP, 411 WEST PUTNAM AVE, SUITE 125, GREENWICH CT 06830
Charles E Davidson	10 percent owner	C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602, WEST PALM BEACH FL 33401
Wexford Capital Lp	10 percent owner	777 WEST PUTNAM AVENUE, 1ST FLOOR, GREENWICH CT 06830
Joseph Jacobs	10 percent owner	C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602 EAST, WEST PALM BEACH FL 33401
Wexford Spectrum Trading Ltd	10 percent owner	411 WEST PUTNAM AVENUE, SUITE 125, GREENWICH CT 06830

OncoVista Innovative Therapies Headlines

No Headlines